Molecular mechanisms of the antiglycative and cardioprotective activities of Psidium guajava leaves in the rat diabetic myocardium

References

• Ahmed MS, Ahmed N. 2006. Antiglycation properties of aged garlic extract: possible role in prevention of diabetic complications. J Nutr. 136:796–799.
   Web of Science ®Google Scholar
• Andrews NC, Faller DV. 1991. A rapid micropreparation technique for extraction of DNA binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499.
   PubMed Web of Science ®Google Scholar
• Baynes JW, Thorpe SR. 2000. Glycoxidation and lipoxidation in atherogenesis. Free Radic Biol Med. 28:1708–1716.
   PubMed Web of Science ®Google Scholar
• Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J, Hanssen KF. 1999. Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care. 22:1186–1190.
   PubMed Web of Science ®Google Scholar
• Burnette WN. 1981. Western blotting: electrophoretic transfer of proteins from sodium dodecyl sulfate polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radio iodinated protein A. Anal Biochem. 112:195–203.
   PubMed Web of Science ®Google Scholar
• Candido R, Forbes JM, Thomas MC, Thallas V, Dean RG, Burns WC, Tikellis C, Ritchie RH, Twigg SM, Cooper ME, et al. 2003. A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes. Circ Res. 92:785–792.
   PubMed Web of Science ®Google Scholar
• Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ. 2002. Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation. 106:246–253.
   PubMed Web of Science ®Google Scholar
• Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. 2000. CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol. 32:1805–1819.
   PubMed Web of Science ®Google Scholar
• Collins T. 1993. Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest. 68:499–508.
   PubMed Web of Science ®Google Scholar
• Goldin A, Beckman JA, Schmidt AM, Creager MA. 2006. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 114:597–605.
   PubMed Web of Science ®Google Scholar
• Gopal VR, Indira M. 2010. Investigations on the correlation of advanced glycated end products (AGE) associated fluorescence with blood glucose and oxidative stress in ethanol-administered diabetic rats. Exp Toxicol Pathol. 62:157–162.
   PubMed Web of Science ®Google Scholar
• Gutiérrez RM, Mitchell S, Solis RV. 2008. Psidium guajava: a review of its traditional uses, phytochemistry and pharmacology. J Ethnopharmacol. 117:1–27.
   PubMed Web of Science ®Google Scholar
• Halliwell B. 2001. Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging. 18:685–716.
   PubMed Web of Science ®Google Scholar
• Inamoto S, Hayashi T, Tazawa N, Mori T, Yamashita C, Nakano D, Matsumura Y, Okuda N, Sohmiya K, Sakai A, et al. 2006. Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia. Circ J. 70:787–792.
   PubMed Web of Science ®Google Scholar
• Jakus V, Rietbrock N. 2004. Advanced glycation end products and the progress of diabetic vascular complications. Physiol Res. 53:131–142.
   PubMed Web of Science ®Google Scholar
• Koitabashi N, Arai M, Kogure S. 2007. Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension. 49:1120–1127.
   PubMed Web of Science ®Google Scholar
• Kunt T, Forst T, Früh B, Flohr T, Schneider S, Harzer O, Pfützner A, Engelbach M, Löbig M, Beyer J. 1999. Binding of monocytes from normo lipidemic hyperglycemic patients with type 1 diabetes to endothelial cells is increased in vitro. Exp Clin Endocrinol Diabetes. 107:252–256.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680–685.
   PubMed Web of Science ®Google Scholar
• Li JH, Wang W, Huang XR, Oldfield M, Schmidt AM, Cooper ME, Lan HY. 2004. Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway. Am J Pathol. 164:1389–1397.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Maseri A. 2002. Inflammation and atherosclerosis. Circulation. 105:1135–1143.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein determination with Folin reagent. J Biol Chem. 195:133–140.
   Google Scholar
• Nakagawa T, Yokozawa T, Terasawa K, Shu S, Juneja LR. 2002. Protective activity of green tea against free radical-and glucose-mediated protein damage. J Agr Food Chem. 50:2418–2422.
   PubMed Web of Science ®Google Scholar
• Newton TR, Patel NM, Bhat-Nakshatri P, Stauss CR, Goulet RJ Jr, Nakshatri H. 1999. Negative regulation of transactivation function but not DNA binding of NF-kappaB and AP-1 by IkappaBbeta1 in breast cancer cells. J Biol Chem. 274:18827–18835.
   PubMed Web of Science ®Google Scholar
• Nishikimi T, Maeda N, Matsuoka H. 2006. The role of natriuretic peptides in cardioprotection. Cardiovasc Res. 69:318–328.
   PubMed Web of Science ®Google Scholar
• Noh HJ, Kim HC, Lee SS, Kang YN, Chae YM, Park KK. 2006. The inhibitory effect of siRNAs on the high glucose-induced overexpression of TGF-beta1 in mesangial cells. J Korean Med Sci. 21:430–435.
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Vannucci SJ, Yan SS, Herold K, Yan SF, Schmidt AM. 2005. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neuro degeneration, and inflammation. Glycobiology. 15:16–28.
   PubMed Web of Science ®Google Scholar
• Sharma K, Ziyadeh FN. 1994. Renal hypertrophy is associated with upregulation of TGF-β1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol. 267:1094–1101.
   Web of Science ®Google Scholar
• Singh R, Barden A, Mori T, Beilin L. 2001. Advanced glycation end-products: a review. Diabetologia. 44:129–146.
   PubMed Web of Science ®Google Scholar
• Soman S, Rajamanickam C, Rauf AA, Indira M. 2013. Beneficial effects of Psidium guajava leaf extract on diabetic myocardium. Exp Toxicol Pathol. 65:91–95.
   PubMed Web of Science ®Google Scholar
• Soman S, Rauf AA, Indira M, Rajamanickam C. 2010. Antioxidant and antiglycative potential of ethyl acetate fraction of Psidium guajava leaf extract in streptozotocin-induced diabetic rats. Plant Foods Hum Nutr. 65:386–391.
   PubMed Web of Science ®Google Scholar
• Sun M, Yokoyama M, Ishiwata T, Asano G. 1998. Deposition of advanced glycation end products (AGE) and expression of the receptor for AGE in cardiovascular tissue of the diabetic rat. Int J Exp Pathol. 79:207–222.
   PubMed Web of Science ®Google Scholar
• Wu CH, Yen GC. 2005. Inhibitory effect of naturally occurring flavonoids on the formation of advanced glycation endproducts. J Agric Food Chem. 53:3167–3173.
   PubMed Web of Science ®Google Scholar
• Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H. 1997. Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension. 29:728–735.
   PubMed Web of Science ®Google Scholar
• Zhou G, Li C, Cai L. 2004. Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol. 165:2033–2043.
   PubMed Web of Science ®Google Scholar